Biotechnology Science/R&D jobs in San Diego
Broaden your search
- Science/R&D, Biotechnology, San Diego, California 34
- Science/R&D, Biotechnology, Doctorate/PHD/MD, California 41
Refine your search
-
Biotechnology
Remove selection
-
Science/R&D
Remove selection
- Biology 1
- Biotechnology 4
- Chemistry 2
- CMC 1
- Laboratory 2
- Oncology 2
- Pharmacology 2
- Research 2
-
San Diego
Remove selection
-
Doctorate/PHD/MD
Remove selection
Found 8 Doctorate/PHD/MD jobs
-
Manager, Drug Product
Vaccitech plc is a fast-growing biotech company. At only six years old we already have a development portfolio of nine programmes, including a part...
Top job
-
Senior Vice President, CMC
Job Type Full-time Position Summary A key member of its leadership team is the role of Senior Vice President, Chemistry, Manufacturing and Con
-
Senior Scientist, Formulation Development
Job Description Position: Senior Scientist I, Formulation Development Reporting To: Position: Senior Scientist II, Formulation Development Positi...
-
Director, Medicinal Chemistry (Cambridge, MA or San Diego, CA)
The Director of Medicinal Chemistry manages a group of internal or/and external chemists to advance discovery projects
-
Executive Director, Cancer Biology
Responsible for leading and building a team, and, in a ‘hands-on’ fashion, contributing to all stages of small molecule
-
Scientist, Chemistry
Job Title: Scientist, Chemistry Location: San Diego, California Position type: Full Time Required education: Ph.D. in organic/medicinal chemistry, bio
-
Director / Senior Director, Translational Research
Job Type Full-time Position Summary: The (Senior) Director Translational Research will lead a team of researchers focusing on translational experim
-
Senior Director, Clinical Scientist – San Diego Preferred but will consider remote
Senior Director, Clinical Scientist – SD Preferred but will consider remote We’re a different kind of biotech company. And we’re here to make a diff
-
Director Clinical Pharmacology Pharmacometrics
Company Overview Avidity Biosciences is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitat